In the original article, we neglected to include the Wrocław Centre of Biotechnology as a funding source. The full Funding statement should read as follows:
This work was financially supported by the project “Innovative Bacteriophage Preparation for the Treatment of Diabetic Foot” no. POIG.01.03.01-02-048/12 funded by the National Center for Research and Development. MŁ contribution was financially supported by the statutory funds for the Institute of Biochemistry and Biophysics, PAS. Publication was also supported by Wrocław Centre of Biotechnology, programme, the Leading National Research Centre (KNOW) for years 2014–2018.
The authors apologize for this oversight. This error does not change the scientific conclusions of the article in any way.
Statements
Conflict of interest
BW-D and AG are inventors of a patent (EP1 406 642 B1, PL 19543781, US 7, 232564 B2) for procedure of preparing phages against S. aureus and P. aeruginosa (P382800; US 20100227376 A1) and a method of obtaining bacteriophage preparations containing trace amounts of endotoxins owned by the Institute of Immunology and Experimental Therapy. EJ-M, MŁ, MŻ, MŁ-S, declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Summary
Keywords
bacteriophage isolation, therapeutic phages, experimental phage therapy, treatment of bacterial infections, antibiotic resistance
Citation
Weber-Dąbrowska B, Jończyk-Matysiak E, Żaczek M, Łobocka MB, Łusiak-Szelachowska M and Górski A (2016) Corrigendum: Bacteriophage Procurement for Therapeutic Purposes. Front. Microbiol. 7:1813. doi: 10.3389/fmicb.2016.01813
Received
17 October 2016
Accepted
28 October 2016
Published
09 November 2016
Volume
7 - 2016
Edited and reviewed by
Peter Mullany, University College London, UK
Updates
Copyright
© 2016 Weber-Dąbrowska, Jończyk-Matysiak, Żaczek, Łobocka, Łusiak-Szelachowska and Górski.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Beata Weber-Dąbrowska weber@iitd.pan.wroc.pl
This article was submitted to Antimicrobials, Resistance and Chemotherapy, a section of the journal Frontiers in Microbiology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.